Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of Advanced Conduction Disturbances Requiring a Late (≥48 H) Permanent Pacemaker Following Transcatheter Aortic Valve Replacement.
Mangieri A, Lanzillo G, Bertoldi L, Jabbour RJ, Regazzoli D, Ancona MB, Tanaka A, Mitomo S, Garducci S, Montalto C, Pagnesi M, Giannini F, Giglio M, Montorfano M, Chieffo A, Rodès-Cabau J, Monaco F, Paglino G, Della Bella P, Colombo A, Latib A. Mangieri A, et al. Among authors: montalto c. JACC Cardiovasc Interv. 2018 Aug 13;11(15):1519-1526. doi: 10.1016/j.jcin.2018.06.014. JACC Cardiovasc Interv. 2018. PMID: 30093056 Free article.
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.
Costa F, Montalto C, Branca M, Hong SJ, Watanabe H, Franzone A, Vranckx P, Hahn JY, Gwon HC, Feres F, Jang Y, De Luca G, Kedhi E, Cao D, Steg PG, Bhatt DL, Stone GW, Micari A, Windecker S, Kimura T, Hong MK, Mehran R, Valgimigli M. Costa F, et al. Among authors: montalto c. Eur Heart J. 2023 Mar 14;44(11):954-968. doi: 10.1093/eurheartj/ehac706. Eur Heart J. 2023. PMID: 36477292
Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials.
Montalto C, Costa F, Leonardi S, Micari A, Oreglia JA, Vranckx P, Capodanno D, Ten Berg J, Lopes RD, Valgimigli M. Montalto C, et al. Eur Heart J Cardiovasc Pharmacother. 2023 Apr 10;9(3):220-230. doi: 10.1093/ehjcvp/pvac065. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36427063
Usefulness of Predilation Before Transcatheter Aortic Valve Implantation.
Pagnesi M, Jabbour RJ, Latib A, Kawamoto H, Tanaka A, Regazzoli D, Mangieri A, Montalto C, Ancona MB, Giannini F, Chieffo A, Montorfano M, Monaco F, Castiglioni A, Alfieri O, Colombo A. Pagnesi M, et al. Among authors: montalto c. Am J Cardiol. 2016 Jul 1;118(1):107-12. doi: 10.1016/j.amjcard.2016.04.018. Epub 2016 Apr 21. Am J Cardiol. 2016. PMID: 27184169
Clinical outcomes following bifurcation double-stenting with bioresorbable scaffolds.
Tanaka A, Latib A, Kawamoto H, Jabbour RJ, Mangieri A, Pagnesi M, Montalto C, Regazzoli D, Ancona M, Chieffo A, Carlino M, Montorfano M, Colombo A. Tanaka A, et al. Among authors: montalto c. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):854-862. doi: 10.1002/ccd.26579. Epub 2016 May 17. Catheter Cardiovasc Interv. 2016. PMID: 27184769
Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation.
Tanaka A, Jabbour RJ, Kawamoto H, Mangieri A, Pagnesi M, Montalto C, Chieffo A, Carlino M, Montorfano M, Latib A, Colombo A. Tanaka A, et al. Among authors: montalto c. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):865-870. doi: 10.1002/ccd.26586. Epub 2016 May 24. Catheter Cardiovasc Interv. 2016. PMID: 27219102
98 results